Respiratory Syncytial Virus Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Pfizer Launches VaxAssist, to Help Individual’s Assess Respiratory Vaccine Eligibility
As more respiratory vaccinations have become available in recent years, the Centers for Disease Control and Prevention (CDC) continues to provide annual guidelines for common respiratory illnesses—COVID-19, pneumococcal pneumonia, influenza (the flu), and respiratory syncytial virus (RSV)—to help ensure eligible populations are seeking vaccinations, especially during respiratory illness season.1,2,3,4,5,6 Pfizer has launched VaxAssist, an online tool that helps adults 18 and older check their...
The Power of Partnership in our Mission to Better Connect the Patient Health Journey
Since the start of the COVID-19 pandemic, we have known that it would take unprecedented collaboration across multiple industries to tackle the virus. As we have strived together to bring breakthrough science to the world, a constant in our work has been collaborating with other organizations on solutions that streamline the patient journey and simplify the ways in which people learn about vaccines and treatment. I was proud to highlight these efforts on behalf of Pfizer during a recent...
Easing the Healthcare Burden of the Seasonal Triple-demic and Pfizer’s Unwavering Commitment to Public Health
As the cooler fall and winter months approach, we prepare for the potential seasonal increase in cases of certain respiratory viruses including—COVID-19, influenza (flu), and respiratory syncytial virus (RSV). Coined a "triple-demic," the concurrent surge of these three respiratory illnesses not only threatens our individual states of health, but can also place a greater burden on healthcare systems worldwide, diverting resources away from other patients in need. In the 2022-2023 season...
Maternal Immunization: Protecting Children from RSV and GBS
In the first few months of their lives, infants experience new sights, sounds, scents, and textures. During this time, they also make contact with new organisms. It takes up to three months for portions of infants’ still-developing immune systems to mature.1 During these early weeks and months, infants are too young to receive their first vaccines, leaving them vulnerable to developing serious infections.2Most pregnant people transmit antibodies to their developing fetuses naturally starting in...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.